/PRNewswire/ Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and.
Evogene Financial Results and Earnings Announcement Schedule for the First Quarter of 2021
USA - English
Share this article
Share this article
REHOVOT, Israel, May 12, 2021 /PRNewswire/ Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announces today that it will release its financial results for the first quarter of 2021 on Wednesday, May 26
th, 2021. Mr. Ido Dor, Chief Executive Officer of Evogene s subsidiary, Lavie Bio Ltd., will join the conference call to discuss Lavie Bio s recent activity.
On the day of the announcement, the Company s management will host a conference call to discuss the results at 09:00 AM Eastern time, 16:00 Israel time. To access the conference call, please dial +1-888-281-1167 toll free from the United States, or +972-3-918-0609 internationally. Access to the call will also be available via live webcast through the Company s w
Filings submitted in Austria, Israel, and Serbia for a Phase 2 Clinical Trial with INM-755 cream
Additional submissions slated for France, Germany, Greece, .
Evogene to Hold Virtual Investor & Analyst Days
USA - English
English language event on Wednesday, April 21, 2021
News provided by
Share this article
Share this article
REHOVOT, Israel, April 7, 2021 /PRNewswire/ Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company today announced that it will hold virtual investor and analyst days, in both Hebrew and English, via Zoom webinars.
The meetings will feature key-note presentations from Evogene s CEO, Ofer Haviv, and the CEOs of Evogene group subsidiaries Biomica, Canonic, AgPlenus, and Lavie Bio, followed by a question and answer session.
The Hebrew language event will be held on Monday, April 19, 2021 at 4pm IST or 9am ET. To register for this event, please visit the link:
Share:
ST. LOUIS, Mo. and REHOVOT, Israel, March 17, 2021 /PRNewswire/
Plastomics, Inc., an agricultural biotech company, developing a step change in trait delivery technology, and Evogene Ltd. s, (NASDAQ:EVGN) (TASE: EVGN), Ag-Seed division, focusing on discovery and development of seed traits, announced today a collaboration agreement targeting novel insect control traits for soybean.
As part of the collaboration, Plastomics, utilizing its disruptive new technology, will introduce Evogene s insect control genes demonstrating new modes of action (MoAs) into soybeans. These genes, which were discovered using Evogene s GeneRator AI engine, have demonstrated insecticidal activity in different assays to controlling insect colonies that are resistant and susceptible to current commercial insect solutions. a significant challenge to soybean growers.